- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
Patent holdings for IPC class A61K 31/4375
Total number of patents in this class: 3538
10-year publication summary
248
|
223
|
296
|
268
|
271
|
298
|
302
|
301
|
339
|
22
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Deciphera Pharmaceuticals, LLC | 201 |
66 |
Novartis AG | 11254 |
61 |
F. Hoffmann-La Roche AG | 7942 |
45 |
Incyte Corporation | 963 |
43 |
Immunomedics, Inc. | 279 |
42 |
Bristol-myers Squibb Company | 4863 |
41 |
Bayer Pharma AG | 1085 |
41 |
Merck Patent GmbH | 5842 |
39 |
Merck Sharp & Dohme LLC | 3751 |
35 |
Boehringer Ingelheim International GmbH | 4754 |
34 |
Takeda Pharmaceutical Company Limited | 2943 |
27 |
Hoffmann-La Roche Inc. | 3267 |
26 |
Pfizer Inc. | 3368 |
25 |
Bayer AG | 3209 |
25 |
Shenzhen HighTide Biopharmaceutical, Ltd. | 52 |
25 |
Merck Sharp & Dohme Corp. | 2219 |
24 |
Gilead Sciences, Inc. | 1951 |
24 |
Pliant Therapeutics, Inc. | 61 |
22 |
Genentech, Inc. | 3869 |
21 |
Mayo Foundation for Medical Education and Research | 3115 |
21 |
Other owners | 2851 |